Recce Pharmaceuticals (STU:R9Q) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Recce Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Recce Pharmaceuticals's Free Cash Flow for the six months ended in Dec. 2024 was €-4.20 Mil. Recce Pharmaceuticals's Revenue for the six months ended in Dec. 2024 was €0.00 Mil. Therefore, Recce Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Recce Pharmaceuticals's current FCF Yield % is -131.76%.

The historical rank and industry rank for Recce Pharmaceuticals's FCF Margin % or its related term are showing as below:

STU:R9Q's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -144.89
* Ranked among companies with meaningful FCF Margin % only.

Recce Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Recce Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recce Pharmaceuticals FCF Margin % Chart

Recce Pharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

FCF Margin %

Get a 7-Day Free Trial

Recce Pharmaceuticals Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
FCF Margin %	Get a 7-Day Free Trial													-	-	-	-	-

Competitive Comparison of Recce Pharmaceuticals's FCF Margin %

For the Biotechnology subindustry, Recce Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Recce Pharmaceuticals's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Recce Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Recce Pharmaceuticals's FCF Margin % falls into.

Recce Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Recce Pharmaceuticals's FCF Margin for the fiscal year that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	-8.113	/	0
	=	%

Recce Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-4.199	/	0
	=	%

Recce Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Recce Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Recce Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Recce Pharmaceuticals Ltd (STU:R9Q) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

RCE:Australia

Address

180 George Street, Level 23, Salesforce Tower, Sydney, NSW, AUS, 2000

Website

https://www.recce.com.au

Recce Pharmaceuticals Ltd is an Australia-based globally-focused biotechnology company engaged in the development and commercialization of a new class of antibiotics. The company operates in only one business segment being research and development of pharmaceutical drugs. The firm operates in three geographic segments being Australia, the United Kingdom, and the United States of America, of which the majority of the revenue comes from Australia. The company offers antibiotic drugs to treat diseases caused by various bacteria namely Sepsis, Neisseria gonorrhoeaei, Escherichia coli, Mycobacterium abscessus, and others.

Recce Pharmaceuticals Headlines

No Headlines